Letter to the Editor regarding 'Estetrol (E4): the new estrogenic component of combined oral contraceptives'.

Letter to the Editor regarding 'Estetrol (E4): the new estrogenic component of combined oral contraceptives'. Expert Rev Clin Pharmacol. 2020 Sep 28;: Authors: Bennink HJC PMID: 32981383 [PubMed - as supplied by publisher]
Source: Expert Review of Clinical Pharmacology - Category: Drugs & Pharmacology Tags: Expert Rev Clin Pharmacol Source Type: research